Department of Thoracic Oncology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong Province, China.
Guangdong Esophageal Cancer Research Institute, Guangzhou, China.
Ann Surg Oncol. 2024 Jun;31(6):3830-3838. doi: 10.1245/s10434-024-14937-2. Epub 2024 Jan 20.
The study aimed to evaluate the efficacy of using near-infrared fluorescent imaging (NIRF) imaging with indocyanine green as an intraoperative tool for achieving complete mediastinal lymph node (LN) resection.
Between September 2019 and July 2021, patients with potential for esophagectomy due to middle and lower thoracic esophageal cancer were enrolled in this study. All patients were scheduled for NIRF-guided mediastinal lymphadenectomy during esophageal cancer surgery and were appropriately assigned to the NIRF group. Patients who underwent esophagectomy between September 2017 and September 2019 were assigned to the historical control group upon satisfying the inclusion/exclusion criteria. Surgical outcomes and the number of removed LNs were compared between the two groups using 1:1 propensity score matching.
Of 67 eligible patients, 59 patients were included in the NIRF group after postsurgical exclusions. The operative time was significantly shorter in the NIRF group than in the historical control group [180 (140-420) min versus 202 (137-338) min; P < 0.001]. The incidence of postoperative chylothorax and hoarseness were significantly lower in the NIRF group than in the historical control group (0% versus 10.2 %; P = 0.036, 3.4% versus 13.6%; P = 0.047). The number of dissected total LNs, mediastinal LNs, and negative LNs was significantly larger in the NIRF group than in the historical control group. The number of overall metastatic LNs and abdominal LNs was comparable between the two groups.
NIRF imaging can assist in the thorough and complete mediastinal LNs dissections without increasing complications in patients undergoing esophagectomy.
本研究旨在评估使用近红外荧光成像(NIRF)技术联合吲哚菁绿(ICG)作为术中工具,实现完全纵隔淋巴结(LN)切除的效果。
2019 年 9 月至 2021 年 7 月期间,因中下段胸段食管癌而有潜在手术机会的患者被纳入本研究。所有患者均计划在食管癌手术中接受 NIRF 引导的纵隔淋巴结清扫术,并被适当分配至 NIRF 组。符合纳入/排除标准的 2017 年 9 月至 2019 年 9 月间行食管癌切除术的患者被分配至历史对照组。采用 1:1 倾向评分匹配比较两组患者的手术结果和切除的 LN 数量。
67 例符合条件的患者中,术后排除后有 59 例患者纳入 NIRF 组。NIRF 组的手术时间明显短于历史对照组[180(140-420)min 比 202(137-338)min;P < 0.001]。NIRF 组的术后乳糜胸和声音嘶哑发生率明显低于历史对照组(0%比 10.2%;P = 0.036,3.4%比 13.6%;P = 0.047)。NIRF 组的总清扫 LN、纵隔 LN 和阴性 LN 数量明显多于历史对照组。两组的总转移性 LN 和腹部 LN 数量相当。
NIRF 成像可以协助彻底、完整地清扫纵隔 LN,而不会增加食管癌患者的并发症。